FRCA Notes


Principles of Cardiopulmonary Bypass


  • Cardiopulmonary bypass (CPB) has allowed surgeons to operate in a relatively bloodless field whilst still achieving organ perfusion
  • The morbidity and mortality for routine cardiac cases is <5% and CPB is not directly implicated in the majority of these cases

Advantages Disadvantages
Secured gas exchange Abnormal blood flow distribution
Greater flow to muscle than GI or hepatic circulations
Guaranteed cardiac ouput Inflammatory pathway activation
MAP control by changing flow & vascular resistance Embolic damage
Can provide pulsatile or continuous flow Coagulopathy
Allows control of body temperature Errors e.g. mechanical or human (rare)


The circuitry itself

  • Modern CPB often involves the use of minimised circuits (MiECC), characterised by:
    • Small priming volumes (e.g. approx. 600ml vs. historic 1800ml)
    • Tip-to-tip coating of the contact surfaces
    • Closed systems
    • Use of centrifugal pumps (instead of roller pumps)
    • Avoidance of cardiotomy suction and vents, using mechanical salvage of red blood cells

  • Contact of blood with the circuit induces a systemic inflammatory response and coagulation system activation involving leucocytes, platelets and complement
  • Said response is reduced by coating the circuit and oxygenator with a biocompatible material such as heparin, phosphorylcholine or PMEA

  • Gas emboli within the circuitry contribute to neurological complications of CPB
  • The circuitry is thus completely de-aired before surgery, e.g. with a CO2 flush, in order to reduce neurocognitive impairment from such gaseous microemboli

  • The circuitry is also primed prior to use
  • Use of crystalloid and colloid solutions is associated with haemodilution, coagulopathy and extravasation of fluid
  • Minimising the circuit-prime volumes, and using autologous priming, helps reduce the haematological impact of priming

Venous side

  • Deoxygenated blood drains from the right heart, by gravity, into the venous reservoir
  • Inadequate venous flow risks air entrainment, and may be due to air locks, kinks in or clamps on the tubing, or poor cannula placement

  • Shed blood describes blood taken from cardiotomy suction, pleural or pericardial vents/drains, or the wounds
    • Historically it was pumped into a cardiotomy (shed blood) reservoir before being mixed into the venous reservoir and thus into the CPB machine
    • This blood is, however, highly activated by the negative pressure on the suction lines and blood-air interfaces
    • This state is associated with activation of both the clotting cascade and inflammatory pathways
    • Reinfusion is shed blood is associated with neurological injury, cognitive decline and acute lung injury
  • Therefore in modern CPB shed blood is handled using a cell salvage machine, reducing the pathological activation of the blood, before returning it

  • In the venous reservoir, deoxygenated blood is mixed with filtered shed blood
  • This mixed blood is pumped through a heat exchanger, and then into the oxygenator (gas exchanger)

Oxygenator (gas exchanger)

  • A hollow-fibre, microporous membrane system is used to oxygenate blood from the venous side of the circuit
  • The system has a relatively high intrinsic resistance, hence requiring blood to be pumped through
  • Modern oxygenators have a reduced area of blood-gas interface (a source of inflammatory response) and are extremely efficient

  • Gas exchange occurs according to Fick's law of diffusion:
  • Rate ∝ KA(ΔC)/D

    • K = diffusion constant
    • A = area for diffusion
    • ΔC = concentration gradient
    • D = distance of diffusion

  • Compared to the lungs, oxygenators have a lower surface area (3.5m2vs. 100m2) and greater distance of diffusion (200μm vs. 10μm)
  • As such, they rely on higher pressure gradients (e.g. up to 760mmHg i.e. 100kPa) to ensure gas exchange

Arterial side

  • Oxygenated blood leaves the gas exchanger and passes through an aortic filter
  • A combination of screen filtration and depth filtration is used to minimise:
    • Embolic load (solid, gaseous and fat), which is associated with organ injury including cognitive dysfunction
    • Inflammatory response by using a leucocyte-depleting filter

  • Oxygenated blood then passes into the aorta, distal to the aortic cross-clamp, and is thus pumped through the systemic circulation

Monitoring

  • Perfusionists rely on a range of monitoring and safety devices:
Monitoring and safety devices during CPB
Mixed venous blood saturation monitors (SvO2)
Real-time (continuous) in-line blood gas analysers both pre- and post-oxygenator
Oxygenator arterial outlet temperature monitoring
Regional cerebral tissue oxygenation using NIRS
Line pressure monitors
Emergency bypass routes
Manual control of rotary pumps
Ports facilitating sampling and addition of fluids/components


  • Opening of the venous line allows passive flow to the venous reservoir
  • As venous flow increases, the aortic flow will be gradually increased to ∽2.5L/min
    • The target flow is historically estimated using BSA and temperature, although lean body mass may be a more sensitive estimate of systemic metabolic requirements
    • Measurements of DO2 provided by the CPB machine need to incorporate [Hb] and SaO2, which may help further determine the requisite pump flow
  • Once suitable pump flow is acheived, CPB is fully established and ventilation of the lungs can cease
  • The heart is usually completely emptied by CPB, but this mayn't occur until after aortic cross-clamping e.g. in severe AR or presence of shunts

  • Even pulsatile CPB flow leads to a low pulse pressure, so MAP is a more accurate variable to monitor
  • Target MAP is usually 50-80mmHg

Hypotension

  • Blood pressure inevitably falls at the onset of CPB due to:
    • Loss of venous return
    • Vasoplegic syndrome

  • Vasoplegic syndrome describes a reduced SVR due to pro-inflammatory mediator release, anaesthetic drugs and other perioperative drugs e.g. calcium channel blockers
  • Prolonged vasoplegia is less common than previously owing to advances in CPB circuit technology and techniques

  • This period of low pressure is often short-lived, and MAP can be maintained through:
    • Vasoconstrictors e.g. perfusionists will use higher-strength phenylephrine (500μg - 1mg doses) to increase vascular resistance
    • Alterations of pump flow, which are a more rapid way of temporarily reducing MAP for surgical needs
    • Use of goal-directed haemodynamic therapy once off CPB to maintain DO2

Hypertension

  • Hypertension on CPB may derive from:
    • Inadequate anaesthesia/analgesia
    • Catecholamine release
    • Hypothermia-induced vasoconstriction
  • Management is with treatment of the underlying cause and use of arterial vasodilators

Temperature control

  • Hypothermia is often instigated
  • The beneficial effect comes from reduced systemic and cerebral oxygen consumption
  • This increases tolerance to the low-flow/low-MAP state during CPB
  • Deep hypothermic cardiac arrest (DHCA) is sometimes used for complex aortic or congenital cardiac surgery

  • See: dedicated page on temperature management during CPB

Acid-base and electrolytes

  • Acid-base status, electrolytes and blood sugar are monitored on a continuous (or at least half-hourly) basis during CPB

  • Metabolic acidosis risks tissue injury and organ dysfunction
  • It arises due to:
    • Tissue hypoxia
    • Electrolyte imbalance
    • Excessive use of 0.9% NaCl or unbalanced colloids

  • In order to reduce post-operative complications associated with acid-base and electrolyte disturbance, recommendations are:
    • In cases of mild-moderate hypothermia (i.e. not DHCA), interpretation of acid-base status using alpha-stat blood gases
    • Maintain pH 7.35-7.45
    • Consider use of magnesium sulphate for arrhythmia prophylaxis
  • Severe metabolic injury and deranged kidney function may benefit from intra-operative haemofiltration

Blood products

  • Haematological variables including ACT, Hb and haematocrit are measured on a half-hourly basis
  • See: dedicated page on anticoagulation during CPB

  • Anti-fibrinolytics are often given, either:
    • Tranexamic acid e.g. 5-6g in divided doses - often for lower risk or elective cases
    • Aprotinin e.g. up to 5,000,000units in divided doses - often for high bleeding risk cases, dissections etc. as the benefit outweighs the risks from aprotinin

  • pRBCs are recommended for:
    • Hb <60g/L or if inadequate DO2 in conjunction with indices of oxygenation (such as SvO2 and O2 extraction ratio)
    • Hct <25% and inadequate tissue oxygenation
  • Patients will have cell-saved blood returned to them at the end of bypass

  • Patients often require clotting factors or other products at the end of bypass, which are titrated according to point of care tests including TEG/ROTEM
  • These include:
    • Prothrombin complex concentrate such as octaplex (factors II, VII, IX and X, protein C and protein S) e.g. 500-1500IU
    • Fresh frozen plasma (factors II, V, VIII, IX, X, and XI, and antithrombin III)
    • Others such as cryoprecipitate less commonly

  • Although systemic hypothermia is cerebro-protective, the myocardium is typically not part of the bypass circuit and requires protection via different means
  • The main techniques used are:
    1. Cardioplegic arrest
    2. Cross-clamp-fibrillation

Cardioplegic arrest

  • A solution of predominantly potassium, as well as other elecltrolytes, is used to arrest the heart in diastole, improving operative conditions
  • It is typically cooled to 4°C but may be warmed
  • It can be administered anterogradely or retrogradely

  • See: dedicated page on cardioplegia

Cross-clamp-fibrillation

  • Intermittent cross-clamping of the aorta and subsequent myocardial ventricular fibrillation (spontaneous on cross-clamping or by use of a DC fibrillating device)
  • Fibrillation can only be safely tolerated for 10 - 15mins so only suitable for quick procedures
  • At the end of the period, the cross-clamp is removed and the heart defibrillated into sinus rhythm

  • At decreased temperature, such as during CPB, there is an increased solubility of gases in blood, most notably CO2
  • Therefore measurement of CO2 and pH at low temperature requires caution
  • This leads to two methods for measuring blood gases during CPB: pH-stat and ɑ-stat

pH-stat

  • In pH-stat, the pH is kept constant at 7.4 by addition of CO2 to the oxygenator and blood gas parameters are corrected by temperature
  • The pH is measured at the actualy patient temperature, giving a relative hypercarbia

  • Using pH-stat blood gas management increases CO2 content during cooling
    • As cerebral blood flow is controlled by PCO2, pH-stat tends to lead to cerebral vasodilation and an increase in CBF
    • Autoregulation, however, is lost and CBF becomes pressure-dependent
  • This leads to better cerebral cooling but risk of increased micro-emboli load

ɑ-stat

  • ɑ-stat measures blood gas variables inc. pH at a constant 37°C, without the addition of CO2, and alkalosis is permitted during cooling
  • ɑ-stat blood gas readings are interpreted uncorrected for body temperature

  • Using ɑ-stat may normalise, or reduce, the CBF with the consequence of reduced efficiency of cerebral cooling

  • In most centres the ɑ-stat is used, as the majority of post-operative neurological injury is caused by micro- and macro-emboli
  • In the paediatric population, however, the pH-stat is often used as the hypoperfusing effect is more dominant with regards to neurological outcome
  • Some centres use pH-stat on cooling but ɑ-stat on re-warming

  • A multi-disciplinary effort requiring adequate communication between the perioperative team
  • Use of a checklist is recommended

Criteria for CPB weaning

Criteria Notes
Lung ventilation re-established Re-expansion & resumption of ventilation
De-airing of cardiac chambers & grafts (particularly LA/LV) Aided by TOE
Aortic cross-clamp removed Restores coronary artery (and graft) blood flow
HR and rhythm compatible with weaning May require epicardial pacing esp. if prolonged CPB or existing conduction defects
Need for inotropy/IABP considered Target MAP >60mmHg, no one inotrope known to be superior
Normothermia (36 - 37°C) Both hypothermia and hyperthermia are harmful
Normal electrolytes and acid-base balance May necessitate use of bicarbonate
Adequate Hb and Hct Should be maintained throughout CPB

Haemodynamic instability post-CPB

  • As the aortic cross-clamp is removed, may need vasoactive support to combat ventricular dysfunction or vasoplegia, both of which are common following CPB
  • Low cardiac output states are associated with:
    • ↑ morbidity
    • Higher short-term and long-term mortality
    • ↑ resource utilisation
  • Management is to correct the cause (e.g. graft dysfunction, hypovolaemia) and use of positive inotropy, or vasopressors, as indicated

  • Predictors of requiring vasopressor support Predictors of requiring inotropic support
    Use of ACE-I or other vasodilators pre-operatively Poor LVEF or known heart failure
    Septic patient Symptoms of heart failure e.g. SOBOE, oedema
    High intra-operative phenylephrine requirement Multiple heart failure medications
    ↑ duration of CPB (as greater SIRS response) ↑ duration of cross-clamping
    Residual ischaemic heart disease e.g. not possible to undertake all planned grafts
    MVR for mitral regurgitation; the sudden ↑ in LV afterload may precipitate failure

  • Options for vasopressor support include noradrenaline (1st line), vasopressin, methyline blue or high-dose hydroxycobalamin
  • Options for inotropic support include dopamine, milrinone, low-dose adrenaline or IABP